期刊
MEDIATORS OF INFLAMMATION
卷 2016, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2016/5609121
关键词
-
资金
- Taiwan Ministry of Science and Technology [NSC 99-2320-B-350-002-MY3, MOST 104-2320-B-039-016-MY3]
- Cheng-Hsin General Hospital-National Yang-Ming University Cooperation Project [98F117CY09]
- Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]
- China Medical University [CMU105-S-19]
Peroxisome proliferator-activated receptor alpha (PPAR alpha) plays a role in the pathogenesis of cardiac hypertrophy, although its underlying mechanism remains unclear. The purpose of this study was to evaluate the effect of PPAR alpha activation on endothelin-1-(ET-1-) caused cardiomyocyte hypertrophy and explore its underlying mechanisms. Human cardiomyocytes (HCMs) were cultured with or without ET-1, whereafter the inhibitory effects of fenofibrate, a PPAR alpha activator, on cell size and adiponectin protein were tested. We examined the activation of extracellular signal-regulated kinase (ERK) and p38 proteins caused by ET-1 and the inhibition of the ERK and p38 pathways on ET-1- induced cell size and adiponectin expression. Moreover, we investigated the interaction of PPAR alpha with adiponectin and nuclear factor-kappa B (NF-kappa B) by electrophoretic mobility shift assays and coimmunoprecipitation. ET-1 treatment significantly increased cell size, suppressed PPAR alpha expression, and enhanced the expression of adiponectin. Pretreatment with fenofibrate inhibited the increase in cell size and enhancement of adiponectin expression. ET-1 significantly activated the ERK and p38 pathways, whereas PD98059 and SB205380, respectively, inhibited them. Our results suggest that activated PPAR alpha can decrease activation of adiponectin and NF-kappa B and inhibit ET-1- induced cardiomyocyte hypertrophy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据